$HQY

HealthEquity, Inc.: HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results

HealthEquity reported Q2 2026 revenue of $350.7M (+8%), net income of $65.6M (+10%), and adjusted EBITDA of $167.0M (+11%). HSA assets grew 14% to $37.9B. The company raised fiscal 2027 guidance and repurchased $108.1M in shares.

Original reporting
Published Aug 27, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 12:34 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HQY
Bullish
high confidence
Mentioned
$HQY
Relevance
9/10
alphai data visualization · based on finanznachrichten.de
Decision brief

The 30-second read

$HQYBullishHigh
01

Why it matters

Earnings beat and raised guidance likely to drive short‑term buying pressure.

02

Market read

Strong earnings and guidance upgrade make HQY a notable earnings mover.

03

What to watch

Potential regulatory changes to HSAs could affect future growth.

Relevance 9/10Novelty 9/10Timing: today

Background

HealthEquity is the largest independent HSA custodian, reporting Q2 2026 results and FY 2027 outlook.

Company-level read

Ticker impact

$HQYBullishHigh confidence
Context

HealthEquity reported Q2 2026 results with revenue up 8% and raised FY 2027 guidance to $1.411‑$1.421B.

Expected impact

Potential price appreciation on earnings beat and raised outlook.

Evidence & confidence

Revenue and earnings beat expectations; guidance increase signals growth, likely to attract buying.

Market effects

Positive for HSA/benefits management sector, may lift peers.

U.S. health‑benefits market sees increased investor interest.

Limited to U.S. listed health‑savings providers.

Counterpoint

Guidance may already be priced in; watch for execution risk.

Key entities

  • Scott Cutler

    President and CEO of HealthEquity, quoted on results.

Related articles

$HQYHighAI 8/10

HealthEquity, Inc. Q2 2027 Earnings Call Summary

HealthEquity, Inc. reported Q2 2027 record adjusted EBITDA margins of 48% and 24% new HSA sales growth. The company raised fiscal 2027 revenue guidance to $1.411B–$1.421B and plans to roll out a next-gen app. Invested HSA assets increased 28% YoY. Management highlighted AI-driven cost reductions and Marketplace growth.

$HQYMed

Why is HealthEquity stock sliding today?

HealthEquity (HQY) stock fell 7.6% pre-market after Q2 FY2027 results met expectations but lacked upside. Revenue rose 8% to $350.7M, EPS increased 15% to $1.24. CEO highlighted record metrics, and guidance was raised. The decline is attributed to modest earnings growth and high market expectations.

$HQYHigh

HEALTHEQUITY, INC. (HQY): Results of Operations and Financial Condition

HEALTHEQUITY, INC. (HQY) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results Highlights of the second quarter include: • Net income increased 10% to $65.6 million , and net income margin increased to 19% from 18% last year. • Adjusted EBITDA increased 11% to $167.0 million , and Adj

$HQYMed

HealthEquity rating upgraded by Moody’s on strong cash flow

Moody’s upgraded HealthEquity, Inc. (NASDAQ:HQY) corporate family rating to Ba2 from Ba3 and raised its probability of default rating to Ba2-PD from Ba3-PD. It also upgraded $600 million senior unsecured notes to Ba3 from B1, with outlook changed to stable. Moody’s cited stronger operating cash flow and BenefitWallet integration, plus improved leverage and liquidity.

$HQYMedAI 9/10

HealthEquity Q1 2027 Earnings Call: Complete Transcript - HealthEquity (NASDAQ: HQY)

HealthEquity reported fiscal 2027 first-quarter results, citing 7% year-over-year revenue growth and a record adjusted EBITDA margin of 46%, according to the company. It raised guidance to $1.41–$1.42B revenue and $625–$633M adjusted EBITDA. The firm said it expanded digital engagement and Marketplace, used AI for efficiency, saw HSA assets +19% and new HSA sales +15%, and increased its share repurchase authorization by $1B.